GAD2 and small cell lung carcinoma: Another patient, a 42-year-old male positive for anti-GABABR, GAD65, Ma2, and SOX1 antibodies, was diagnosed with small cell lung cancer and treated with IVIg, ASMs, and platinum-based chemotherapy, dying 1 year after diagnosis.